HeartMate 3 ELEVATE™ Registry

Abbott

Status: Completed

Conditions: Ventricular Dysfunction; Heart Failure; Cardiovascular Disease

Treatments: Device: HeartMate 3

Study type: Observational

Funder types: Industry

Identifiers

NCT02497950

HeartMate 3™ Registry

Details and patient eligibility

About

Evaluate real-world experience of HeartMate 3 (HM3) in post-approval setting.

Full description

The purpose of this post-market registry is to collect data and evaluate the real-world experience of the HeartMate 3 Left Ventricular Assist System (HM3 LVAS) in a post-approval setting.

Enrollment: 540 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion:

1. Patient consented to registry data collection
2. Patient has met the HeartMate 3 commercially approved labeling indication and is implanted with the HM3.

Trial design

540 participants in 1 patient group

HeartMate 3

Description:

This registry will include all patients that receive the HM3 LVAS in the post-market setting

Treatment:

Device: HeartMate 3